ABI-007

nab-paclitaxel · Celgene Corporation

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for ABI-007, covering 2006-07-13 to 2019-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of ABI-007 for In-Stent Restenosis [Phase 2]